Lundbeck Canada is a subsidiary of H. Lundbeck A/S, an international research-based pharmaceutical company focused on brain diseases and oncology. Based in Montreal, Lundbeck Canada has been active in the Canadian pharmaceutical industry for almost two decades, marketing products for the treatment of depression, anxiety, Alzheimer’s disease, schizophrenia, bipolar disorders, chronic lymphocytic leukemia, non-Hodgkin lymphoma, and acute promyelocytic leukemia.

Through research, development, education, and partnerships with other companies and patient organizations, Lundbeck employees are improving the quality of life for people living with brain diseases and cancer.

Welcome to Lundbeck

Experience our video and learn why caring is our culture at Lundbeck Canada.